Literature DB >> 19412801

The Swedish Birth Defects Registry: ascertainment and incidence of spina bifida and cleft lip/palate.

Hashem Amini1, Ove Axelsson, Birgitta Ollars, Göran Anneren.   

Abstract

OBJECTIVES: To assess the ascertainment of spina bifida and cleft lip/palate (CLP) in newborns and in fetuses from terminated pregnancies (ToPs) in the Swedish Birth Defects Registry (BDR) and to estimate the true incidences of these two anomalies.
DESIGN: Retrospective register study.
SETTING: Center for Epidemiology at the Swedish National Board of Health and Welfare, and Uppsala University Hospital. POPULATION: Newborns and fetuses from ToPs with spina bifida (1999-2004) and CLP (1999-2002) in Sweden.
METHODS: Data from four registries/sources were used to estimate ascertainment in BDR and incidences of spina bifida and CLP. MAIN OUTCOME MEASURE: Ascertainment, under-ascertainment, and true incidence.
RESULTS: For newborns, under-ascertainment of spina bifida and CLP were 6 and 13%, respectively, in BDR after record linkage with the Medical Birth Registry. Ascertainment of cleft palate increased when accompanied by cleft lip. The under-ascertainment of spina bifida in ToPs after 18 gestational weeks was 27%. Ascertainment of CLP in all ToPs and of spina bifida in ToPs before the 18th gestational week could not be estimated. The majority (109/155, 70%) of ToPs with spina bifida occurred before the 18th week. The estimated incidence of spina bifida per 10,000 births was 6.1 (2.4 newborns and 3.7 ToPs) and of CLP 20.1 (18.9 newborns and 1.2 ToPs).
CONCLUSION: The ascertainments are relatively high for newborns in BDR, but lower or unknown for ToPs, which has an impact on the surveillance of spina bifida in view of the high proportion of ToPs.

Entities:  

Mesh:

Year:  2009        PMID: 19412801     DOI: 10.1080/00016340902934696

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  7 in total

1.  Incidence of cleft lip and palate in gorgan - northern iran: an epidemiological study.

Authors:  Arezou Mirfazeli; Nafiseh Kaviany; Kaniz Reza Hosseinpour; Mohammad Jafar Golalipour
Journal:  Oman Med J       Date:  2012-11

2.  Medical databases in studies of drug teratogenicity: methodological issues.

Authors:  Vera Ehrenstein; Henrik T Sørensen; Leiv S Bakketeig; Lars Pedersen
Journal:  Clin Epidemiol       Date:  2010-08-09       Impact factor: 4.790

Review 3.  Global Birth Prevalence of Spina Bifida by Folic Acid Fortification Status: A Systematic Review and Meta-Analysis.

Authors:  Callie A M Atta; Kirsten M Fiest; Alexandra D Frolkis; Nathalie Jette; Tamara Pringsheim; Christine St Germaine-Smith; Thilinie Rajapakse; Gilaad G Kaplan; Amy Metcalfe
Journal:  Am J Public Health       Date:  2015-11-12       Impact factor: 9.308

Review 4.  Epidemiology, prenatal management, and prevention of neural tube defects.

Authors:  Mustafa A Salih; Waleed R Murshid; Mohammed Z Seidahmed
Journal:  Saudi Med J       Date:  2014-12       Impact factor: 1.484

Review 5.  Pharmacotherapy for Pediatric Neurogenic Bladder.

Authors:  Paweł Kroll
Journal:  Paediatr Drugs       Date:  2017-10       Impact factor: 3.022

6.  Thai Universal Health Care Coverage scheme promotes the accessibility to cleft lip/palate treatment: the result of cleft care provision assessment using modified Geographic Information System.

Authors:  Wannapong Chonnapasatid; Nita Viwattanatipa; Somchai Manopatanakul; Somchit Jaruratanasirikul
Journal:  BMC Health Serv Res       Date:  2022-03-29       Impact factor: 2.655

7.  Ultrasound in Prenatal Diagnostics and Its Impact on the Epidemiology of Spina Bifida in a National Cohort from Denmark with a Comparison to Sweden.

Authors:  Charlotte Rosenkrantz Bodin; Mikkel Mylius Rasmussen; Ann Tabor; Lena Westbom; Eleonor Tiblad; Charlotte Kvist Ekelund; Camilla Bernt Wulff; Ida Vogel; Olav Bjørn Petersen
Journal:  Biomed Res Int       Date:  2018-02-01       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.